Zofran (ondansetron) is a 5-HT3 receptor antagonist primarily used as an antiemetic, but in cluster headache treatment, it may help modulate serotonergic neurotransmission. While not a first-line treatment for cluster headaches, it can potentially reduce the frequency and intensity of attacks by blocking serotonin receptors involved in pain signaling and neurogenic inflammation.